Skip to content

Idealpharma

Active
Private limited company (pre-2019)founded 2004active for 22 yearsHeidestraat 1, 2660 Antwerpen, BelgiumKBO/BCE: BE 0864.605.936
Summary

The computed 12-month bankruptcy probability of Idealpharma is 1.8% (moderate). The annual accounts of Idealpharma for financial year 2025 show a net loss of 78% of the equity at the start of that year. The 2025 annual accounts show equity of €55,469 and a net result of -€193,427. Equity is growing by about 3.8% per year across the filed financial years. Its solvency ranks better than 18% of 12,650 sector peers (NACE 47, financial year 2025). The company has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals.

History

Idealpharma was incorporated on 8 April 2004.1 Total assets rose from €713,470 in 2018 to €804,498 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
28-07
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial Weakest financial yearnet -€193,427
Net result drops to -€193,427, the lowest in the series.
30-09
NBB filing Annual accounts filed
financial year 2024 · abbreviated format · 61 days late
2024
18-09
Gazette deed Resignation: Erik Van Nuffel (director)
3 facts ▸
  • General meeting, 30-07-2024
  • Director resignation, Erik Van Nuffel (director)
  • Other provision, director discharge, 30-07-2024
30-08
NBB filing Annual accounts filed
financial year 2023 · abbreviated format · 30 days late
2023
05-08
NBB filing Annual accounts filed
financial year 2022 · abbreviated format · 5 days late
2022
28-07
NBB filing Annual accounts filed
financial year 2021 · abbreviated format
2021
23-08
NBB filing Annual accounts filed
financial year 2020 · abbreviated format · 23 days late
2020
31-12
Financial Equity above €200,000equity €238,842 ▲19.5%
A profit in every financial year since 2018 builds equity to €238,842.
26-08
NBB filing Annual accounts filed
financial year 2019 · abbreviated format · 26 days late
2019
31-12
Financial Highest result from 2018 to 2025net €168,012 ▲96.6%
Operating result €224,343, net result €168,012, both a record.
31-12
Financial Equity above €150,000equity €199,926 ▲51.6%
A profit in every financial year since 2018 builds equity to €199,926.
Show earlier events
26-07
NBB filing Annual accounts filed
financial year 2018 · abbreviated format
2018
31-07
NBB filing Annual accounts filed
financial year 2017 · abbreviated format
2017
28-07
NBB filing Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 21 annual accounts filed, the latest 10 are here; all 21 are under Financials.
1 of 5 deeds read
About the unread acts

Of the 5 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.